Skip to main content
Clinical Trials/NCT02604095
NCT02604095CompletedNot Applicable

Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism

Shanghai 10th People's Hospital1 site in 1 country16 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
16
Locations
1
Primary Endpoint
insulin resistance index

Study Overview

Brief Summary

Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism.

Detailed Description

The effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism in patient with obesity and acanthuses nigrican.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age:18-60 years old;
  • BMI ≥ 28 kg/m2;
  • With acanthosis nigricans。

Exclusion Criteria

  • With liver, kidney, gastrointestinal or other major organic serious diseases, cancer, lactating women, pregnancy.

Arms & Interventions

Melatonin

Experimental

Take one table at bedtime.

Intervention: melatonin (Dietary Supplement)

Outcomes

Primary Outcomes

insulin resistance index

Time Frame: 12 weeks

HOMA-IR:serum fasting insulin(mmol/L) × serum fasting glucose(mmol/L)/22.5

Secondary Outcomes

  • Neck circumference(12 weeks)
  • Triglyceride(12 weeks)
  • Low Density Lipoprotein(12 weeks)
  • Blood pressure(12 weeks)
  • Waist circumference(12 weeks)
  • High Density Lipoprotein(12 weeks)
  • Body weight(12 weeks)
  • Body fat(12 weeks)
  • Total Cholesterol(12 weeks)

Investigators

Sponsor
Shanghai 10th People's Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zhang Manna

Professor

Shanghai 10th People's Hospital

Study Sites (1)

Loading locations...

Similar Trials